Back to search

Article

Investigating the role of genomic drivers of MET pathway dysregulation in the heterogeneity of pleomorphic lung carcinoma

2019-01-01

Abstract excerpt

Background: Pleomorphic Lung Carcinoma (PC) is a rare lung cancer that is aggressive and poorly responsive to treatments. It is a highly heterogenous tumour and unique as it has at least 10% dedifferentiated sarcomatoid component alongside its epithelial components. Recent data have demonstrated a high frequency of mutations in the MET receptor that may support epithelial to mesenchymal transition (EMT) as an impo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0544b887-43cf-5a58-a94d-1c05dbef89c7
DOI
10.25560/78719
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigating the role of genomic drivers of MET pathway dysregulation in the heterogeneity of pleomorphic lung carcinomaDOI 10.25560/78719
Select a neighboring publication to make it the new centre.